↓ Skip to main content

Dove Medical Press

Article Metrics

What is this page? Embed badge

Clinical outcome of primary small cell carcinoma of the urinary bladder

Overview of attention for article published in OncoTargets and therapy, August 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
19 Mendeley
Summary Twitter Dimensions citations
Title
Clinical outcome of primary small cell carcinoma of the urinary bladder
Published in
OncoTargets and therapy, August 2013
DOI 10.2147/ott.s49879
Pubmed ID
24009428
Authors

Ke-Hung Tsui, Chen-Pang Hou, Yu-Hsiang Lin, Chien-Lun Chen, Phei-Lang Chang

Abstract

Primary small cell carcinoma of the urinary bladder is a rare malignant disease. It accounts for less than 1% of all urinary bladder carcinomas. The purpose of this study is to review the clinical features, the treatment modalities, and the overall survival of these patients. We also compare the clinical outcomes between patients of bladder small cell carcinoma (SCC) and bladder urothelial carcinoma (UC).

View on publisher site

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 26%
Professor > Associate Professor 4 21%
Researcher 3 16%
Professor 1 5%
Lecturer 1 5%
Other 2 11%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 7 37%
Agricultural and Biological Sciences 2 11%
Business, Management and Accounting 1 5%
Environmental Science 1 5%
Materials Science 1 5%
Other 1 5%
Unknown 6 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2013.
All research outputs
#18,355,685
of 22,733,113 outputs
Outputs from OncoTargets and therapy
#1,484
of 2,928 outputs
Outputs of similar age
#148,691
of 198,422 outputs
Outputs of similar age from OncoTargets and therapy
#23
of 40 outputs
Altmetric has tracked 22,733,113 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,928 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,422 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.

This page is hosted by Altmetric on behalf of Dove Medical Press.